Delivery Order SPE2DB20D2104-SPE2DB25FMYXC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,350.29 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,534.28 for 60 mg Brilinta tablets (60-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,234.42 for Brilinta 90 mg tablets (60-count units) with a firm fixed price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Brilinta 90 mg tablets (60-count packaging) with a ceiling value of $7,397.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,501.34 to AmerisourceBergen Drug Corp for the supply of Brilinta (ticagrelor) 90 mg tablets in a 60-tablet package. The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under a larger...
- The Defense Logistics Agency awarded a $1,303.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on June 20, 2025, with completion scheduled for June 23, 2025. This competitive award, made without a set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (100 unit dose packages) on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYXCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. The Brilinta delivery fulfills DLA's ongoing need for essential cardiovascular medications to sustain Defense Health Agency operations and other federal healthcare beneficiary populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/26/25 |